2715P Phase II trial of tildrakizumab in treatment-refractory bone and soft tissue sarcomas
Authors:
- M. KansaraMKM. Kansara
- F.P. LinFLF.P. Lin
- S. ThavaneswaranSTS. Thavaneswaran
- M.L. HuangMHM.L. Huang
- M. TranMTM. Tran
- T. CorpuzTCT. Corpuz
- J. LuJLJ. Lu
- D. EspinozaDED. Espinoza
- S. ChinchenSCS. Chinchen
- M. BallingerMBM. Ballinger
- P. GrimisonPGP. Grimison
- V. AndelkovicVAV. Andelkovic
- 6 November 2025
- journal article
- Published by Elsevier in Annals of Oncology
- Vol. 36, S1350-S1351
Abstract
No abstract availableFunding Information
- Bayer
- Roche